Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

http://www.wikidata.org/entity/Q35621236

about

Hypoxia-inducible factors as molecular targets for liver diseases Hypoxia and Hypoxia-Inducible Factors in Leukemias HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions.MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.Prognostic significance and clinicopathological features of hypoxic inducible factor-2alpha expression in hepatocellular carcinoma.PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery.The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.The role of hypoxia-inducible factor-2 in digestive system cancers.Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.The role of hypoxia-inducible factors in tumorigenesis.Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma.Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein.Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.The impact of hypoxia in hepatocellular carcinoma metastasis.Hypoxia inducible factors in hepatocellular carcinoma MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1.HIF-2α attenuates lymphangiogenesis by up-regulating IGFBP1 in hepatocellular carcinoma.Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.Cezanne regulates E2F1-dependent HIF2α expression.Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression.Frequent alteration of the protein synthesis of enzymes for glucose metabolism in hepatocellular carcinomas.Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.Association of PHD3 and HIF2α gene expression with clinicopathological characteristics in human hepatocellular carcinoma.

P2860

Q26752304-7566C6AE-9AEE-427E-946F-8120641B2252 Q26767167-6A69AA81-6A28-486A-B27D-7E7AF13020E3 Q27025886-6A7A30D6-8B8E-4E8E-AC3A-A8AD1A552AFE Q28385588-FB9CD6FF-D7A5-4955-B7C1-5E61D683A3E3 Q31142350-98F96498-583B-403E-9566-96E34D932C67 Q33788030-9C5A27CC-565E-4228-89CA-80B8E5862CB3 Q33908602-D1A192B7-54E6-4B11-922B-82E528DB797C Q34221413-D5C5B0AA-0D96-4172-99D1-82B4C034BAB8 Q34288613-82F06952-118C-4D14-B0B2-EE4D1AF3ECEE Q35009536-2E0350CD-50F3-4A2F-B5B8-AD64C2504B94 Q35222046-428AE3EB-9680-458F-8424-8A808E03E523 Q35793653-3CAD9828-6009-4BEC-815C-ED48318C483B Q36023978-277445DF-A7E4-447A-9952-5CD500385812 Q36300487-07692F54-7B4B-4B74-A6C6-38EC38B18068 Q36304128-070D363D-A5FC-4F7F-8A40-A57F96026511 Q36346439-EADB88CC-BC83-4E2E-830B-B172D598BAB1 Q36347140-89860B34-8BE5-42CA-8284-F3A339FED6D0 Q36675088-B74F332D-EDB7-47F0-980E-402EAA3DF610 Q37079708-AD12BC10-C6CC-4A59-9FFB-E88285A7D209 Q37249932-BCF42DB7-14C4-446C-BDAF-49E267EA0B23 Q37376342-EA073787-C2E8-404C-8056-90A0E40F219B Q37463877-6E222911-088C-4C2D-81B4-90F1AA4A9D73 Q37701609-F28EC792-6B77-4BF0-98CE-D0813341000F Q37706535-9FB74D42-096B-4F3A-ADF1-0A89A1343303 Q37706763-A632C62C-57CA-4082-8DAD-66133107039B Q37961603-B5C750D8-0BF0-4715-B063-E35411420549 Q38162804-0DF7B21F-2CDF-419F-A7CA-592225A38287 Q38685135-7B7E946B-0E8C-40BC-8D3B-7901E3182C12 Q38730419-ED0A73DB-6612-4AB4-A28E-BE24CA4AD628 Q38901614-AB4439CC-58A6-4414-B1F4-4E6D0321E5EC Q38924905-BB62CAAB-0231-426F-BAAD-9A992C17D20A Q39012517-C3970D39-B519-40AC-AC7B-189A65C3498B Q39716016-14BBF35F-BEED-4282-8FDD-F9011DBCD45B Q40607212-332212C6-4546-46FE-A940-C4792FC3D380 Q40764538-60021F3B-A6DC-43B4-B309-4FD287C2A043 Q42831020-03B4704A-5EA7-44ED-9D1D-2EC22251301C Q42867141-87DA0025-E778-4C78-A0BD-D76F3EEED0D7 Q43050082-851C9A07-BA22-4030-9091-B98E8CFF512E Q45350842-FE49CBE6-6D7F-467C-8DDD-C96E3F725252 Q49433413-BAF7F194-96F8-4AB9-933D-9D249EF597D0

P2860

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

http://www.wikidata.org/entity/Q35621236

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

@ast

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

@en

type

label

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

@ast

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

@en

prefLabel

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

@ast

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

@en

P1433

Q35621236-0C6E06D5-17FF-43FF-87CE-6B267EDD47C4

P1476

Q35621236-4BD667C6-5079-4BA9-A2AA-1A2BAAF450D8

P2093

Q35621236-0E8D8AEC-D7AC-4401-918B-85AC1616A605

Q35621236-4B829A21-5FBA-4FE8-A4ED-124DF2604E8D

Q35621236-781802C4-1797-435E-9D9A-8456E9507C37

Q35621236-89F24E99-F0B4-4A5F-973B-7F01C70ACDA4

Q35621236-B12E7B94-75FE-4FDF-8B37-6401EFC27ECA

Q35621236-F8D5D42D-6BD0-4222-ACD2-ABAA8F8B3BB5

P2860

Q35621236-0221711F-D258-4396-98D3-41C4EDDF862A

Q35621236-04307A02-1D93-420D-B875-850BBFCD0D9E

Q35621236-14A70BBC-B902-4780-87C2-A98C92A3A9F0

Q35621236-205B5AF6-2F25-4FD5-A083-A6BD015D0718

Q35621236-2108B10C-49F2-4A49-9C89-B0CCC431AF30

Q35621236-36DDD184-BEE8-4EAF-A2BF-C795213765CD

Q35621236-4A6FDFDD-8656-4FD8-A841-9A31D7E3E11A

Q35621236-4E70B08A-86D9-4952-A0CD-8D7F752ABB5A

Q35621236-5B6CFC93-F72A-4272-A9E0-2893A4EDA55B

Q35621236-5C40BEAC-4FF1-4FF3-89DC-A780F16DBDB6

P304

Q35621236-27355A1F-AB41-4670-9F9A-6F2ED78F3520

P31

Q35621236-D15D6609-94ED-4E31-BA42-95F41B6BAD90

P356

Q35621236-D074B89B-57BB-4A1D-9FEE-EBAB2FFE6B6A

P407

Q35621236-42DBC3BF-840F-4231-9369-EB56AC0DE756

P433

Q35621236-F29A5FA0-0840-4108-8D8B-BE1704E96C69

P478

Q35621236-57CD3D9D-4C12-4E7E-B4D7-9BE201ED2CF2

P577

Q35621236-0094F639-E00F-4EED-9662-9EBE98C8B968

P5875

Q35621236-4656249A-CBFD-4D0B-9224-18F28480993B

P698

Q35621236-B0A79E9F-986F-47F1-89D6-A9788D225F54

P932

Q35621236-D0A3995D-85BD-4A53-B98A-AA7474CB44BE

P356

WJG.V13.I23.3176

P1433

World Journal of Gastroenterology

P1476

Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma

@en

P2093

Cong-Qing Jiang

http://www.w3.org/2001/XMLSchema#string

Gassimou Bangoura

http://www.w3.org/2001/XMLSchema#string

Gui-Fan Yang

http://www.w3.org/2001/XMLSchema#string

Qun Qian

http://www.w3.org/2001/XMLSchema#string

Sun Jing

http://www.w3.org/2001/XMLSchema#string

Zhi-Su Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development

Tumor angiogenesis: therapeutic implications

Angiogenesis in cancer and other diseases

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy

Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha

Angiogenesis in cancer, vascular, rheumatoid and other disease

P304

3176-3182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I23.3176

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6247349

http://www.w3.org/2001/XMLSchema#string

P698

17589895

http://www.w3.org/2001/XMLSchema#string

P932

4436602

http://www.w3.org/2001/XMLSchema#string